UBS Asset Management Americas Inc. Grows Position in CIGNA Co. (CI)

UBS Asset Management Americas Inc. lifted its position in CIGNA Co. (NYSE:CI) by 11.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,686,651 shares of the health services provider’s stock after acquiring an additional 168,740 shares during the period. UBS Asset Management Americas Inc. owned 0.69% of CIGNA worth $342,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CI. Commerzbank Aktiengesellschaft FI grew its position in CIGNA by 19.5% during the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 1,667 shares of the health services provider’s stock worth $339,000 after purchasing an additional 272 shares during the period. Comerica Bank grew its position in CIGNA by 0.4% during the 3rd quarter. Comerica Bank now owns 62,611 shares of the health services provider’s stock worth $12,379,000 after purchasing an additional 274 shares during the period. Investec Asset Management PTY Ltd grew its position in CIGNA by 3.4% during the 3rd quarter. Investec Asset Management PTY Ltd now owns 8,865 shares of the health services provider’s stock worth $1,645,000 after purchasing an additional 290 shares during the period. Barton Investment Management grew its position in CIGNA by 9.6% during the 3rd quarter. Barton Investment Management now owns 3,425 shares of the health services provider’s stock worth $640,000 after purchasing an additional 300 shares during the period. Finally, Bfsg LLC grew its position in CIGNA by 23.1% during the 4th quarter. Bfsg LLC now owns 1,642 shares of the health services provider’s stock worth $333,000 after purchasing an additional 308 shares during the period. 88.60% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have weighed in on CI shares. Citigroup increased their price target on CIGNA from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Jefferies Group increased their price target on CIGNA from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. ValuEngine raised CIGNA from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price target on the stock in a research report on Friday, December 22nd. Finally, Goldman Sachs Group started coverage on CIGNA in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. CIGNA presently has a consensus rating of “Buy” and a consensus price target of $210.12.

In related news, insider Christopher J. Hocevar sold 8,387 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $200.32, for a total value of $1,680,083.84. Following the transaction, the insider now directly owns 12,363 shares of the company’s stock, valued at approximately $2,476,556.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Alan Muney sold 15,345 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $200.80, for a total transaction of $3,081,276.00. Following the completion of the transaction, the executive vice president now directly owns 28,457 shares in the company, valued at $5,714,165.60. The disclosure for this sale can be found here. Insiders sold a total of 64,663 shares of company stock worth $13,329,903 over the last ninety days. 1.30% of the stock is currently owned by corporate insiders.

Shares of CIGNA Co. (NYSE:CI) opened at $193.81 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.39 and a current ratio of 0.37. CIGNA Co. has a 12 month low of $141.93 and a 12 month high of $227.13. The stock has a market cap of $46,827.03, a PE ratio of 18.37, a PEG ratio of 1.15 and a beta of 0.45.

CIGNA (NYSE:CI) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.07. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. The business had revenue of $10.53 billion for the quarter, compared to analyst estimates of $10.28 billion. During the same period in the prior year, the company posted $1.87 EPS. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. research analysts predict that CIGNA Co. will post 12.9 earnings per share for the current year.

WARNING: “UBS Asset Management Americas Inc. Grows Position in CIGNA Co. (CI)” was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.thelincolnianonline.com/2018/02/17/ubs-asset-management-americas-inc-grows-position-in-cigna-co-ci.html.

CIGNA Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply